Research & Literature

Treatment of cystoid macular edema secondary to chronic non-infectious intermediate uveitis with an intraocular dexamethasone implant.

Rossetto JD, Nascimento H, Fernandes DD, et al.

Arquivos brasileiros de oftalmologia 2015; (78(3)):190-3.

Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.

, Kempen JH, Altaweel MM, et al.

Ophthalmology 2015; (122(10)):1967-75.

Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment Trial and Follow-up Study.

Ophthalmology 2015; (122(10)):1976-86.

Discrepancy in Fluorescein Angiography and Optical Coherence Tomography Findings of Macular Edema in Intermediate Uveitis.

Kim BH, Shin JY, Yu HG

Ocular immunology and inflammation 2016; (24(6)):653-659 doi:10.3109/09273948.2015.1063668.

Efficacy of Ozurdex implant in treatment of noninfectious intermediate uveitis.

Palla S, Biswas J, Nagesha CK

Indian journal of ophthalmology 2015; (63(10)):767-70 doi:10.4103/0301-4738.171505.

Remission of Intermediate Uveitis: Incidence and Predictive Factors.

Kempen JH, Gewaily DY, Newcomb CW, et al.

American journal of ophthalmology 2016; (164()):110-7.e2.

Primary vitreoretinal lymphoma: an update on pathogenesis, diagnosis and treatment.

Reichstein D

Current opinion in ophthalmology 2016; (27(3)):177-84 doi:10.1097/ICU.0000000000000255.

Corticosteroid implants for chronic non-infectious uveitis.

Brady CJ, Villanti AC, Law HA, et al.

The Cochrane database of systematic reviews 2016; (2()):CD010469 doi:10.1002/14651858.CD010469.pub2.

Influence of baseline demographic and clinical characteristics in the visual outcome of intermediate uveitis: a survival analysis.

Abásolo L, Prieto-García Á, Díaz-Valle D, et al.

The British journal of ophthalmology 2016; (100(12)):1651-1655 doi:10.1136/bjophthalmol-2015-307774.

Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis.

Ozdal PC, Berker N, Tugal-Tutkun I

Journal of ophthalmic & vision research 2015; (10(4)):469-80 doi:10.4103/2008-322X.176897.

Spectral-domain optical coherence tomography findings of the macula in 500 consecutive patients with uveitis.

Grajewski RS, Boelke AC, Adler W, et al.

Eye (London, England) 2016; (30(11)):1415-1423 doi:10.1038/eye.2016.133.

Phacoemulsification with Intraocular Lens Implantation in Pediatric Uveitis: A Retrospective Study.

Ganesh SK, Mistry S

Ocular immunology and inflammation 2018; (26(2)):305-312 doi:10.1080/09273948.2016.1206944.

Use of Immunosuppressive Medications for Treatment of Pediatric Intermediate Uveitis.

Hersh AO, Cope S, Bohnsack JF, et al.

Ocular immunology and inflammation 2018; (26(4)):642-650 doi:10.1080/09273948.2016.1255340.

Predictors of Long-Term Visual Outcome in Intermediate Uveitis.

Niederer RL, Sharief L, Bar A, et al.

Ophthalmology 2017; (124(3)):393-398 doi:10.1016/j.ophtha.2016.11.013.

Risk Factors for the Development of Cataract in Children with Uveitis.

Blum-Hareuveni T, Seguin-Greenstein S, Kramer M, et al.

American journal of ophthalmology 2017; (177()):139-143 doi:10.1016/j.ajo.2017.02.023.

Analysis of clinical features and visual outcomes of pars planitis.

Berker N, Sen E, Elgin U, et al.

International ophthalmology 2018; (38(2)):727-736 doi:10.1007/s10792-017-0526-2.

PERIPHERAL RETINOSCHISIS IN INTERMEDIATE UVEITIS.

Pichi F, Srivastava SK, Nucci P, et al.

Retina (Philadelphia, Pa.) 2017; (37(11)):2167-2174 doi:10.1097/IAE.0000000000001463.

Ocular sarcoidosis: new diagnostic modalities and treatment.

Yang SJ, Salek S, Rosenbaum JT

Current opinion in pulmonary medicine 2017; (23(5)):458-467 doi:10.1097/MCP.0000000000000409.

Patterns of uveitis in children at the apex institute for eye care in India: analysis and review of literature.

Takkar B, Venkatesh P, Gaur N, et al.

International ophthalmology 2018; (38(5)):2061-2068 doi:10.1007/s10792-017-0700-6.

Long-term results of pars plana vitrectomy as an anti-inflammatory therapy of pediatric intermediate uveitis resistant to standard medical treatment.

Darsová D, Pochop P, Štěpánková J, Dotřelová D

European journal of ophthalmology 2018; (28(1)):98-102 doi:10.5301/ejo.5001020.

Ultra-Widefield Fluorescein Angiography in Intermediate Uveitis.

Laovirojjanakul W, Acharya N, Gonzales JA

Ocular immunology and inflammation 2019; (27(3)):356-361 doi:10.1080/09273948.2017.1371764.

Complications in Intermediate Uveitis: Prevalence, Time of Onset, and Effects on Vision in Short-Term and Long-Term Follow-Up.

Sancho L, Kramer M, Koriat A, et al.

Ocular immunology and inflammation 2019; (27(3)):447-455 doi:10.1080/09273948.2017.1420203.

Pediatric Uveitis.

Chan NS, Choi J, Cheung CMG

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; (7(3)):192-199 doi:10.22608/APO.2018116.

Primary Vitreoretinal Lymphoma Presenting as a Posterior Capsule Plaque.

Hussain RM, Garoon RB, Duker JS, et al.

Ophthalmic surgery, lasers & imaging retina 2018; (49(9)):732-734 doi:10.3928/23258160-20180831-15.

Patterns of Macular Edema in Uveitis as Diagnosed by Optical Coherence Tomography in Tertiary Eye Center.

Gupta S, Shah DN, Joshi SN, et al.

Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH 2018; (10(19)):39-46 doi:10.3126/nepjoph.v10i1.21687.

Lyme-associated uveitis: Clinical spectrum and review of literature.

Bernard A, Seve P, Abukhashabh A, et al.

European journal of ophthalmology 2020; (30(5)):874-885 doi:10.1177/1120672119856943.

Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.

Rathinam SR, Gonzales JA, Thundikandy R, et al.

JAMA 2019; (322(10)):936-945 doi:10.1001/jama.2019.12618.

The Detection of Occult Retinal Vasculitis on Fluorescein Angiography in Pediatric Uveitis.

Abraham A, Saboo US, Ducca BL, et al.

Ophthalmology. Retina 2020; (4(2)):198-203 doi:10.1016/j.oret.2019.09.007.

Current management of uveitis-associated ocular hypertension and glaucoma.

Kesav N, Palestine AG, Kahook MY, Pantcheva MB

Survey of ophthalmology 2020; (65(4)):397-407 doi:10.1016/j.survophthal.2019.12.003.

Time to disease recurrence in noninfectious uveitis following long-acting injectable fluocinolone acetonide implant.

Cai CX, Skalak C, Keenan RT, et al.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2020; (258(5)):1023-1030 doi:10.1007/s00417-020-04614-x.

Outcomes in patients with chronic uveitis: which factors matter to patients? A qualitative study.

Stolk-Vos AC, Kasigar H, Nijmeijer KJ, et al.

BMC ophthalmology 2020; (20(1)):125 doi:10.1186/s12886-020-01388-y.

[Intermediate Uveitis in Adults and Children - Update].

Walscheid K, Heiligenhaus A

Klinische Monatsblatter fur Augenheilkunde 2020; (237(5)):585-590 doi:10.1055/a-1111-9490.

Predictors of health-related quality of life in Chinese patients receiving treatment for neovascular age-related macular degeneration: a prospective longitudinal study.

Bian W, Wan J, Tan M, et al.

BMC ophthalmology 2020; (20(1)):291 doi:10.1186/s12886-020-01561-3.

Immune modulator therapy compared with vitrectomy for management of complicated intermediate uveitis: a prospective, randomized clinical study.

Shalaby O, Saeed A, Elmohamady MN

Arquivos brasileiros de oftalmologia 2020; (83(5)):402-409 doi:10.5935/0004-2749.20200079.

Insights into multiple sclerosis-associated uveitis: a scoping review.

Casselman P, Cassiman C, Casteels I, Schauwvlieghe PP

Acta ophthalmologica 2021; (99(6)):592-603 doi:10.1111/aos.14697.

Clinical Course and Treatment Paradigms for JIA-related Uveitis and Pars Planitis Uveitis Using Precise Ocular Investigational Methods.

Papasavvas I, Gehrig B, Herbort CP

Klinische Monatsblatter fur Augenheilkunde 2021; (238(4)):458-468 doi:10.1055/a-1354-6452.

Risk of Cataract in Intermediate Uveitis.

Minkus CL, Pistilli M, Dreger KA, et al.

American journal of ophthalmology 2021; (229()):200-209 doi:10.1016/j.ajo.2021.02.032.

Relevance of Brain MRI in Patients with Uveitis: Retrospective Cohort on 402 Patients.

Chirpaz NM, Kerever SMP, Gavoille AM, et al.

Ocular immunology and inflammation 2022; (30(5)):1109-1115 doi:10.1080/09273948.2020.1870145.

Classification Criteria for Sarcoidosis-Associated Uveitis.

American journal of ophthalmology 2021; (228()):220-230 doi:10.1016/j.ajo.2021.03.047.

Classification Criteria For Pars Planitis.

American journal of ophthalmology 2021; (228()):268-274 doi:10.1016/j.ajo.2021.03.045.

Classification Criteria for Syphilitic Uveitis.

American journal of ophthalmology 2021; (228()):182-191 doi:10.1016/j.ajo.2021.03.039.

Classification Criteria for Multiple Sclerosis-Associated Intermediate Uveitis.

American journal of ophthalmology 2021; (228()):72-79 doi:10.1016/j.ajo.2021.03.044.

Surgical management of post-uveitic epiretinal membranes.

Coassin M, Mori T, Mastrofilippo V, et al.

European journal of ophthalmology 2021; 11206721211017750 doi:10.1177/11206721211017750.

Pediatric uveitis: A comprehensive review.

Maleki A, Anesi SD, Look-Why S, et al.

Survey of ophthalmology 2022; (67(2)):510-529 doi:10.1016/j.survophthal.2021.06.006.

Long-Term Outcomes of Pediatric Idiopathic Intermediate Uveitis.

AlBloushi AF, Solebo AL, Gokhale E, et al.

American journal of ophthalmology 2022; (237()):41-48 doi:10.1016/j.ajo.2021.11.003.

Intermediate Uveitis: A Review.

Teo AYT, Betzler BK, Hua KLQ, et al.

Ocular immunology and inflammation 2023; (31(5)):1041-1060 doi:10.1080/09273948.2022.2070503.

Predictive Factors for Magnetic Resonance Imaging Changes Suggestive of Demyelination in Adult Patients with Uveitis Scanned Prior to Commencing Adalimumab Therapy.

Sanghi P, Luis J, Ajamil S, et al.

Ocular immunology and inflammation 2023; (31(9)):1804-1812 doi:10.1080/09273948.2022.2118134.

Development and Psychometric Properties of the Chronic Uveitis-Specific Quality of Life Instrument for Patients with Chronic Uveitis.

Linghu W, Niu M, Sun N, et al.

Ocular immunology and inflammation 2024; (32(2)):194-202 doi:10.1080/09273948.2022.2162926.

Uveitis in children: Epidemiological, clinical and prognostic characteristics.

Rodier-Bonifas C, Rochet E, Seve P, et al.

Journal francais d'ophtalmologie 2023; (46(2)):163-172 doi:10.1016/j.jfo.2022.08.005.

Impact of COVID-19 Confinement on Quality of Life of Patients with Age-Related Macular Degeneration: A Two-Wave Panel Study.

Sanabria MR, Calles-Monar PS, Alonso-Tarancón AM, et al.

Journal of clinical medicine 2023; (12(6)) doi:10.3390/jcm12062394.

Correlation between Morphological Characteristics of Macular Edema and Visual Acuity in Young Patients with Idiopathic Intermediate Uveitis.

Iannetti L, Scarinci F, Alisi L, et al.

Medicina (Kaunas, Lithuania) 2023; (59(3)) doi:10.3390/medicina59030529.

Sarcoidosis-Related Uveitis: A Review.

Giorgiutti S, Jacquot R, El Jammal T, et al.

Journal of clinical medicine 2023; (12(9)) doi:10.3390/jcm12093194.

An Overview of Pediatric Uveitis.

Tuğal-Tutkun İ

Turkish archives of pediatrics 2023; (58(4)):363-370 doi:10.5152/TurkArchPediatr.2023.23086.

Clinical characteristics of intermediate uveitis in adults according to criteria of the SUN working group.

Yargi-Ozkocak B, Altan C, Kemer-Atik B, Basarir B

International ophthalmology 2023; (43(10)):3681-3693 doi:10.1007/s10792-023-02778-z.

Prognostic factors of cataract surgery in patients with uveitis.

Jevnikar K, Počkar S, Umek L, et al.

International ophthalmology 2023; (43(12)):4605-4612 doi:10.1007/s10792-023-02860-6.

Diagnosis and Management of Non-Infectious Uveitis in Pediatric Patients.

Nguyen AT, Koné-Paut I, Dusser P

Paediatric drugs 2024; (26(1)):31-47 doi:10.1007/s40272-023-00596-5.

Pediatric Pars Planitis: A Review.

Khochtali S, Ozdal P, AlBloushi AF, et al.

Ocular immunology and inflammation 2023; (31(10)):1915-1929 doi:10.1080/09273948.2023.2279683.

Anterior Vitreous Objective Assessment in Uveitis: An Anterior Segment Swept Source Optical Coherence Tomography Study.

Invernizzi A, Zaffalon C, Manni P, et al.

Ocular immunology and inflammation 2025; (33(1)):24-32 doi:10.1080/09273948.2024.2339435.

Uveitis Profile in Children and Its Impact on Vision at Queen Rania Children's Hospital.

Otoum MM, Al Adwan NM, Haddad HK, et al.

Cureus 2024; (16(4)):e59136 doi:10.7759/cureus.59136.

Optical coherence tomography features in vitreoretinal lymphoma compared with non-infectious uveitis.

El Zein L, Smith WM, White LJ, et al.

BMC ophthalmology 2024; (24(1)):255 doi:10.1186/s12886-024-03513-7.

Ocular Complications of Intermediate Uveitis.

Amer R, Sharon Y

Ocular immunology and inflammation 2025; (33(4)):548-555 doi:10.1080/09273948.2024.2378370.

[Uveitis and multiple sclerosis : Clinical aspects, diagnostics, management and treatment].

Stübiger N, Ruprecht K, Pleyer U

Die Ophthalmologie 2024; (121(8)):665-678 doi:10.1007/s00347-024-02084-8.

Epidemiology of Intermediate Uveitis.

Besagar S, de-la-Torre A, Thorne J, et al.

Ocular immunology and inflammation 2025; (33(4)):503-511 doi:10.1080/09273948.2024.2408411.

Long-Term Outcomes of Pediatric Pars Planitis: Retrospective Cohort from a Single Tertiary Center in Turkey.

Yılmaz Çebi A, Kılıçarslan O, Uçar D

Ocular immunology and inflammation 2025; (33(4)):556-560 doi:10.1080/09273948.2024.2421386.

Effect of Therapeutic Pars Plana Vitrectomy on Total Immunosuppression Load in Patients with Non-Infectious Uveitis.

Abhishek R, Ali MH, Kempen JH, Basu S

Ocular immunology and inflammation 2025; (33(7)):1180-1187 doi:10.1080/09273948.2024.2437121.

Intraocular Metastatic Lung Adenocarcinoma Masquerading as an Intermediate Uveitis.

Nguyen RD, Livnat I, Krishnan V, et al.

Ocular immunology and inflammation 2026; (34(2)):242-245 doi:10.1080/09273948.2024.2447846.

Vitreous hemorrhage in patients with uveitis: a comparative study between adults and children.

Abroug N, Dridi T, Mourali M, et al.

International ophthalmology 2025; (45(1)):60 doi:10.1007/s10792-024-03403-3.

Clinical Features, Complications, and Treatment Outcomes of Pediatric Pars Planitis Cases in a Tertiary Referral Center.

Gülmez Sevim D, Sener H, Ozer F, et al.

Ocular immunology and inflammation 2025; (33(6)):885-891 doi:10.1080/09273948.2025.2462193.

Clinical characteristics and outcomes of pediatric anterior and intermediate uveitis in China.

Sun N, Zhang M, Liu Z, Zhang X

Molecular immunology 2025; (183()):194-202 doi:10.1016/j.molimm.2025.05.013.

Uveitis in Adults: A Review.

Maghsoudlou P, Epps SJ, Guly CM, Dick AD

JAMA 2025; (334(5)):419-434 doi:10.1001/jama.2025.4358.

Adalimumab versus Conventional Immunosuppression for Uveitis (ADVISE) Trial.

, Jabs DA, Sugar EA, et al.

Ophthalmology 2026; (133(3)):310-325 doi:10.1016/j.ophtha.2025.10.004.

Treatment adherence in chronic uveitis: What does the MARS-5 tell us?

Caglayan M, Ekinci DY, Dertsiz Kozan B

BMC ophthalmology 2026; (26(1)).

Characteristics of Uveitis in European Tertiary Ophthalmology Centers: A Systematic Review and Meta-Analysis.

Cieślik M, Guszkowska M, Bodaghi B, et al.

Ocular immunology and inflammation 2026; (34(4)):858-874 doi:10.1080/09273948.2026.2658756.

Characteristics of JIA-associated uveitis at the age of transition.

Raymond A, Combier A, Hecquet S, et al.

Pediatric rheumatology online journal 2026; (24(1)).